Related Experiment Video
Updated: Oct 21, 2025
14:37
Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
Published on: November 1, 2017
11.3K
An update on pediatric ITP: differentiating primary ITP, IPD, and PID
Rachael F Grace1,2, Michele P Lambert3,4
1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Blood
|September 3, 2021
Summary
Pediatric immune thrombocytopenia (ITP) requires differentiating from other causes of low platelets. Advanced diagnostics aid in identifying ITP and related genetic or immune disorders for effective management.
Area of Science:
- Pediatric Hematology
- Immunology
- Genetics
Background:
- Immune thrombocytopenia (ITP) is the most frequent acquired thrombocytopenia in children.
- ITP results from immune-mediated decreased platelet production and increased platelet destruction.
- Distinguishing ITP from inherited and secondary thrombocytopenic disorders is crucial for appropriate management.
Purpose of the Study:
- To outline the diagnostic evaluation of thrombocytopenia in children, focusing on ITP.
- To emphasize the importance of considering underlying genetic and immune disorders in pediatric ITP.
- To illustrate disease manifestations and treatment strategies through hypothetical patient cases.
Main Methods:
- Review of diagnostic approaches for pediatric thrombocytopenia.
- Integration of clinical history and laboratory features in diagnosis.
- Utilization of advanced testing including genotyping, immunophenotyping, and functional assays.
Main Results:
- Diagnostic algorithms for pediatric thrombocytopenia are becoming increasingly complex.
- Genotyping and advanced immunologic assays enhance etiological specificity.
- Early consideration of secondary ITP due to immune dysregulation can impact management.
Conclusions:
- Comprehensive diagnostic evaluation is essential for children with thrombocytopenia.
- Identifying underlying genetic or immune disorders is key in managing pediatric ITP.
- Hypothetical cases demonstrate effective diagnostic and treatment strategies for pediatric ITP.
Related Concept Videos
01:19PID Controller
290
Proportional-Integral-Derivative (PID) controllers are widely used in various control systems to enhance stability and performance. In a thermostat, it adjusts heating or cooling based on the temperature difference between the actual and desired levels. They are often used in automotive speed systems, effectively managing sudden speed changes while maintaining a constant speed under varying conditions. On the other hand, PI controllers, commonly employed in voltage regulation, enhance stability...
290
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
47
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
47
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
41
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
41
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
42
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
42
01:29Drug Dosing: Infants and Children
52
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
52
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
36
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
36